Results 231 to 240 of about 4,640,867 (405)

CLINICAL UTILITY OF KIDNEY FAILURE RISK EQUATION IN DIABETES AND CHRONIC KIDNEY DISEASE

Ying Guat Ooi, Tharsini Sarvanandan, Nicholas Ken Yoong Hee, Quan Hziung Lim, Hooi Chin Beh, Nur Raziana Rozi, Christine Shamala Selvaraj, Adina Abdullah, Wan Ahmad Hafiz Wan Md Adnan, Sharmila S. Paramasivam, R. Jeyakantha Ratnasingam, Shireene Ratna Vethakkan, Pavai Sthaneswar, Soo Kun Lim, Lee‐Ling Lim   +14 more
openalex   +2 more sources

Kidney Organoids in Drug Development: Integrating Technological Advances and Standardization for Effective Implementation

Advanced Healthcare Materials, EarlyView.
This review examines how emerging enabling technologies enhance the physiological relevance, scalability, and reproducibility of kidney organoids, while advanced analytical approaches support model validation and deepen mechanistic insight into nephrotoxicity.
Helen Kearney, Silvia M. Mihăilă, Lorenzo Moroni, Carlos Mota   +3 more
wiley   +1 more source

Granulomatosis With Polyangiitis Presenting With Kidney Failure: A Case Report. [PDF]

Cureus
Haraziński K, Goliat W, Goliat-Mazurek M, Mazurek D, Jastrzebska I, Kaput A, Poreba K, Bobinski M, Czyszczon A, Tkaczyk A.   +9 more
europepmc   +1 more source

Trends in mortality related to kidney failure and diabetes mellitus in the United States: a 1999–2020 analysis [PDF]

Ahmed Mustafa Rashid, Adeena Jamil, Zoha Khan, Muteia Shakoor, Usama Hussain Kamal, Iqra Israr Khan, Abdullah Akram, Mariam Shahabi, Naser Yamani, Soha Ali, Kanza Fatima, Aamna Kamdi, Muhammad Junaid, Ayesha Mazhar Khan, Jishanth Mattumpuram, Prinka Perswani   +15 more
openalex   +1 more source

Engineered ETS1‐Nanoconjugate Restores Immune Homeostasis through Dual Immune‐Vascular Modulation in Relapsing and Progressive Multiple Sclerosis

Advanced Healthcare Materials, EarlyView.
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang, Si‐Bo Yang, Yan Luo, Xiao‐Di Sun, Bo‐Hao Chang, Da‐Qiang Zhou, Jun‐Jie Jiang, Ya‐Nan Li, Jie‐Hong Wu, Hui‐Juan Jin, Hang Yang, Hang Hu, Yi‐Fan Zhou, Bo Hu   +13 more
wiley   +1 more source

Correction: The impact of frailty and malnutrition on hospitalisation and survival in people with kidney failure. [PDF]

J Nephrol
Dawson J, Smyth B, Ryan M, Randall AM, Clifford K, Thomsett M, Li CK, Brown MA.   +7 more
europepmc   +1 more source

2. Kidney Failure

Nihon Naika Gakkai Zasshi, 2007
Hirokazu Honda, Hisako Nagai, Tadao Akizawa   +2 more
openaire   +1 more source

Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart Failure [PDF]

Tetiana A. Berezina, Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, Alexander Е. Berezin   +4 more
openalex   +1 more source

Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation

Advanced Healthcare Materials, EarlyView.
Ferritin‐doped hybrid nanoparticles triggered accurate tumor‐specific hemorrhage for enhanced in situ photothermal therapy and evoked anti‐tumor immunity. Notably, HFn/GA‐Fe specifically induced tumor hemorrhage 12 h after intravenous injection, resulting in visible color darkening. Through photoacoustic imaging, tumor vessels could be clearly observed
Haidong Zha, Xiao Liang, Long Xi, Jiamao Chen, Wenzhao Zhong, Zhen Yuan, Meng Xu, Ying Zheng   +7 more
wiley   +1 more source

Evaluation of the Dual Impact of Nanotechnologies on Health and Environment Through Alternative Bridging Models

Advanced Healthcare Materials, EarlyView.
This review explores how alternative invertebrate and small‐vertebrate models advance the evaluation of nanomaterials across medicine and environmental science. By bridging cellular and organismal levels, these models enable integrated assessment of toxicity, biodistribution, and therapeutic performance.
Marie Celine Lefevre, Margherita Bernardeschi, Matteo Battaglini, Gianni Ciofani   +3 more
wiley   +1 more source